The United States CAR-T Cell Therapy Market continues to lead global growth, supported by a strong biotechnology ecosystem, advanced healthcare infrastructure, and substantial investments in oncology research. The increasing prevalence of hematological malignancies, growing adoption of personalized cancer therapies, and rising number of regulatory approvals for CAR-T cell products are driving...